# 21 CFR 860.220 De Novo request content.

21 CFR 860.220 De Novo request content., “De Novo request content”, is a CFR section of [21 CFR Part 860, Subpart D—De Novo Classification](https://ontology.bommaritollc.com/id/01a0f094-b6fd-7527-bd0e-a9fbbaa316b2); in force.

IRI: <https://ontology.bommaritollc.com/id/01a0f094-cd10-7702-a357-9c8cf43d3dcb>

Within: [Title 21—Food and Drugs](https://ontology.bommaritollc.com/id/01a0f094-b437-7426-9a1d-f0a9f3d3e1aa) › [21 CFR Chapter I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES](https://ontology.bommaritollc.com/id/01a0f094-b455-74b7-9458-ed95d7b5ea58) › [21 CFR Chapter I, Subchapter H—MEDICAL DEVICES](https://ontology.bommaritollc.com/id/01a0f094-b68f-70af-b8e8-5bb30331a2cf) › [21 CFR Part 860—Medical device classification procedures](https://ontology.bommaritollc.com/id/01a0f094-b89c-764a-8228-4f226c2c13d8) › [21 CFR Part 860, Subpart D—De Novo Classification](https://ontology.bommaritollc.com/id/01a0f094-b6fd-7527-bd0e-a9fbbaa316b2)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [cfr-section 21 CFR 860.220](https://ontology.bommaritollc.com/id/01a0f094-cd11-75cd-8ee3-fb10ca2f43ff)
- `eli:cites`:
  - [21 CFR Part 50—Protection of human subjects](https://ontology.bommaritollc.com/id/01a0f094-b7f0-7092-8cfc-6d60da0417f5)
  - [21 CFR Part 54—Financial disclosure by clinical investigators](https://ontology.bommaritollc.com/id/01a0f094-b7f1-7756-81e5-d0b27d4498d1)
  - [21 CFR Part 56—Institutional Review Boards](https://ontology.bommaritollc.com/id/01a0f094-b7f2-72a4-82d6-ac180848fce4)
  - [21 CFR Part 58—Good laboratory practice for nonclinical laboratory studies](https://ontology.bommaritollc.com/id/01a0f094-b7f3-722a-bdd9-43216f95ec63)
  - [21 CFR Part 807—Establishment registration and device listing for manufacturers and initial importers of devices](https://ontology.bommaritollc.com/id/01a0f094-b892-731b-b51d-f44c5870ab34)
  - [21 CFR Part 812—Investigational device exemptions](https://ontology.bommaritollc.com/id/01a0f094-b896-7341-a342-c3a0aea5ee4f)
  - [21 CFR Part 814—Premarket approval of medical devices](https://ontology.bommaritollc.com/id/01a0f094-b898-70a5-b765-863f7ccc4e96)
  - [21 CFR 3.7 Request for designation.](https://ontology.bommaritollc.com/id/01a0f094-ba49-7487-911d-34fd8a2a5854)
  - [21 CFR 56.104 Exemptions from IRB requirement.](https://ontology.bommaritollc.com/id/01a0f094-bbe9-72ce-a454-a9d92ab27f14)
  - [21 CFR 56.105 Waiver of IRB requirement.](https://ontology.bommaritollc.com/id/01a0f094-bbea-761d-a6a5-6644cd7c3125)
  - [21 CFR 807.100 FDA action on a premarket notification.](https://ontology.bommaritollc.com/id/01a0f094-cc6e-760a-ad7a-7996d21788d0)
  - [21 CFR 812.28 Acceptance of data from clinical investigations conducted outside the United States.](https://ontology.bommaritollc.com/id/01a0f094-cc8d-734c-b07f-77e160d8e2c1)
  - [21 CFR 860.7 Determination of safety and effectiveness.](https://ontology.bommaritollc.com/id/01a0f094-cd05-74d2-a302-f79de03dd313)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/CFR-2025-title21-vol1](https://ontology.bommaritollc.com/id/01a0f094-cd10-7702-a357-9c8bc2863d5a)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f094-e520-7755-a398-fbe66b48dcd2)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0d0-c8eb-70de-9d75-0f8d07fd0e17)
  - [evidence from https://www.govinfo.gov/link/cfr/21/860?sectionnum=220&year=mostrecent&link-type=details](https://ontology.bommaritollc.com/id/01a10f17-6b6a-73fd-a4d3-61acefee168a)
- `schema:isPartOf`: [21 CFR Part 860, Subpart D—De Novo Classification](https://ontology.bommaritollc.com/id/01a0f094-b6fd-7527-bd0e-a9fbbaa316b2)
- `schema:legislationIdentifier`: 21 CFR 860.220
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationLegalForce`: [schema:InForce](https://schema.org/InForce)
- `schema:legislationType`: [CFR section](https://ontology.bommaritollc.com/vocab/leg/cfrSection)
- `schema:name`: De Novo request content
- `schema:url`: [https://www.govinfo.gov/link/cfr/21/860?sectionnum=220&year=mostrecent&link-type=details](https://www.govinfo.gov/link/cfr/21/860?sectionnum=220&year=mostrecent&link-type=details)
- `skos:prefLabel`: 21 CFR 860.220 De Novo request content.

## Elsewhere

- [Official page](https://www.govinfo.gov/link/cfr/21/860?sectionnum=220&year=mostrecent&link-type=details) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/CFR-2025-title21-vol1) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

## Pointing here

- Cited by (1; `eli:cites`):
  - [21 CFR 860.230 Accepting a De Novo request.](https://ontology.bommaritollc.com/id/01a0f094-cd11-75cd-8ee3-fb12646b9002)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f094-cd10-7702-a357-9c8cf43d3dcb.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f094-cd10-7702-a357-9c8cf43d3dcb.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f094-cd10-7702-a357-9c8cf43d3dcb.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f094-cd10-7702-a357-9c8cf43d3dcb)
Cite as: 21 CFR 860.220 De Novo request content.. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f094-cd10-7702-a357-9c8cf43d3dcb
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
